A detailed history of Vanguard Group Inc transactions in Opko Health, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 29,501,231 shares of OPK stock, worth $36.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,501,231
Previous 39,751,293 25.79%
Holding current value
$36.9 Million
Previous $60 Million 41.02%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$0.87 - $1.57 $8.92 Million - $16.1 Million
-10,250,062 Reduced 25.79%
29,501,231 $35.4 Million
Q4 2023

Feb 14, 2024

BUY
$1.23 - $1.63 $527,079 - $698,487
428,520 Added 1.09%
39,751,293 $60 Million
Q3 2023

Nov 14, 2023

BUY
$1.5 - $2.17 $17,983 - $26,016
11,989 Added 0.03%
39,322,773 $62.9 Million
Q2 2023

Aug 14, 2023

SELL
$1.37 - $2.17 $3.07 Million - $4.87 Million
-2,244,148 Reduced 5.4%
39,310,784 $85.3 Million
Q1 2023

May 15, 2023

BUY
$1.06 - $1.61 $460,504 - $699,445
434,438 Added 1.06%
41,554,932 $60.7 Million
Q4 2022

Feb 10, 2023

BUY
$1.05 - $2.01 $877,507 - $1.68 Million
835,721 Added 2.07%
41,120,494 $51.4 Million
Q3 2022

Nov 14, 2022

SELL
$1.81 - $2.81 $4.16 Million - $6.45 Million
-2,296,471 Reduced 5.39%
40,284,773 $76.1 Million
Q2 2022

Aug 12, 2022

BUY
$2.33 - $3.61 $15.2 Million - $23.5 Million
6,509,113 Added 18.04%
42,581,244 $108 Million
Q1 2022

May 13, 2022

BUY
$2.87 - $4.93 $995,049 - $1.71 Million
346,707 Added 0.97%
36,072,131 $124 Million
Q4 2021

Feb 14, 2022

BUY
$3.52 - $5.15 $913,580 - $1.34 Million
259,540 Added 0.73%
35,725,424 $172 Million
Q3 2021

Nov 12, 2021

SELL
$3.44 - $4.24 $917,090 - $1.13 Million
-266,596 Reduced 0.75%
35,465,884 $129 Million
Q2 2021

Aug 13, 2021

BUY
$3.33 - $4.55 $119 Million - $163 Million
35,732,480 New
35,732,480 $145 Million

Others Institutions Holding OPK

About OPKO HEALTH, INC.


  • Ticker OPK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 771,960,000
  • Market Cap $965M
  • Description
  • OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...
More about OPK
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.